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Suture-Less Trocar Site Closure for Postoperative Hernia Prevention following 
Laparoscopic Surgery 
Hares Patel, Dr. Daniel Metzinger, Dakota Waldecker and Dr. Robert S. Keynton 
Introduction: Following laparoscopic surgery, there is a need, in many cases, to close 
trocar sites to prevent hernias. Currently, devices that exist on the market are suture 
based, but the lack of standardization in the suturing techniques together with the time-
consuming nature of the procedure leads to the need for improvement in trocar site 
closure products. Trocar closure sites do not need to be fully closed on the fascial layer; 
rather, sufficiently blocking the hole at the abdominal wall can significantly reduce post-
operative herniation. A retrospective study on trocar site herniation (TSH) after 
laparoscopic surgery indicates a TSH incidence of ~5.2% out of a total of 30,568 adult 
and 1,098 child procedures [7]. Specifically, trocar sizes greater than 10mm, failure to 
suture the fascia, and fast absorbable suture were found to be linked to TSH. Thus, the 
purpose of this study is to present a new, rapid deployment, biodegradable device for 
trocar site closures. 
Methods: The Trocar Site Closure Clip (TSCC) is a biodegradable clip to be inserted 
into the abdominal cavity through a 12mm trocar and retracted to pierce into the 
peritoneum and fascia. The TSCC will be inserted via an applicator through the trocar to 
the abdominal cavity. The trocar will be extracted from the patient. The TSCC will be 
pulled upward into the peritoneum and fascia. The applicator will be released leaving the 
vi 
TSCC to be separated and left in the patient to seal the trocar site. The TSCC is 
composed of polylactic acid and tested in various manufacturing modifications for 
optimization. TSCC prototypes completed bench top testing in dragon skin silicone, 
porcine belly, cadaver, and in a chronic swine model study. 
Results: The results of this study demonstrate proof of concept for a biodegradable trocar 
site closure clip as a potential solution as a reliable trocar site closing and postoperative 
hernia prevention device in laparoscopic surgery. This study shows that the 
biocompatible poly-lactic acid-based device can plug and seal 12mm trocar site openings 
along with in animal peritoneal tissue. 
Conclusion: This study successfully fabricated biocompatible TSCC prototypes using 
commercially-available manufacturing techniques. This study demonstrated the efficacy 
of the TSCC to be inserted into/through a trocar and engage the abdominal wall to plug 
the hole and prevent postoperative herniation.
vii 
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 Currently, there is a need for effective/efficient trocar site closure especially with 
the rise of LAP surgeries to be performed with more surgeons becoming specialized, 
increasing technical capabilities of LAP surgery, and incentives such as lower 
hospitalization time or decreases risk of infection. The development of a rapidly 
deployed, reliable device will result in safer and faster LAP surgeries. Due to the need of 
a simple alternative that surgeons can rely on, a revised suture-less device was prototyped 
at the University of Louisville. The proposed design is inserted into the proximal end of 
the trocar, travels through to the distal end of the trocar to the abdominal wall where 
clinching arms will grip the ends of the separated tissue. The clinician will tug on the 
device applicator to deliver the device into the separated tissue, constricting the wound 
from opening and reducing the possibility of postoperative herniation. To conclude the 
procedure, the operator will rotate the device and snap it off the applicator. The device 
will be left implanted in the cavity to degrade as the wound heals. 
1.2 Purpose of the Study 
The purpose of this study is to continue the work off the previous student’s 
fabrication of the device, update the manufacturing process, and verify that the newly 
designed trocar clip successfully closes a trocar site opening from a trocar greater than 




Laser cut trocar site closure devices fabricated with less than 100% fill and 
sharpened tips will require less insertion and delivery force compared to 3D printed 
trocar site closure devices. 
1.4 Significance of the Study 
The significance of this study is that it will develop a fast method to close trocar 
site wounds by minimizing the amount of time a surgeon will take in suturing the wound 
closed. This device is expected to decrease the incidence of TSH and evolve the current 
capabilities of laparoscopic surgery. 
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II. LITERATURE REVIEW 
2.1 Clinical Problem 
Minimally invasive surgery (MIS) is a modern surgical technique in which 
surgery is performed via 0.5-1.5cm incisions in the abdominal, pelvic, or chest cavity 
(Figure 1). The cavity is inflated with carbon dioxide gas and illuminated with a 
laparoscopic camera. Surgery is executed by the insertion of tools into the anatomical 
opening monitored by the camera. The most evident advantages for patients of MIS 
include: minimized trauma to the abdominal wall, faster convalescence, reduced hospital 
stay, faster return to normal activity, decreased post-operative pain, reduced risk of 
hemorrhaging, and reduced exposure of internal organs. MIS has continuously developed 
and advanced from a minimally invasive diagnostic tool to an efficient instrument for 
surgical treatment of benign and malignant diseases. The ongoing training, experience, 
and development in imaging and laparoscopic instruments have facilitated extension of 
the applications of laparoscopic surgery. The outcome, efficiency, decreased incidence of 
wound infections, and reduced perioperative morbidity of minimally invasive procedures 
have been shown across different applications, e.g., appendectomy, cholecystectomy, 
esophageal surgery, reflux surgery, gastric surgery, colorectal surgery, colon cancer, 
rectal surgery, rectal cancer, liver surgery, pancreatic surgery, splenectomy, hernia repair, 
and adrenalectomy [6] 
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Figure 1: Depiction of laparoscopic tools being used in a MIS procedure within the abdominal cavity. [19] 
The MIS technique has attained progressive global popularity over time with 
complex procedures. In 2013, there were 2.5 million MIS/laparoscopic (LAP) surgical 
procedures performed in the U.S. alone. The ports utilized to insert surgical instruments 
into the inflated cavity in laparoscopic surgery are called trocars. Being the only access 
point for surgeons, trocars are an essential component for LAP surgery. 
The use of trocars in LAP surgery have several benefits for the patient, however, 
also present a risk of developing trocar site herniation post-operatively. A hernia is the 
bulging of an organ from an abnormal opening in the body, visually depicted in Figure 2. 
Post-operative herniation caused by trocar site is the bulging of an organ into the opened 
tissue site from the retracted trocar. A retrospective study on trocar site herniation (TSH) 
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after laparoscopic surgery published in 2011 indicates from a total analysis of 30,568 
adult procedures and 1,098 child procedures, an incidence of TSH of 0-5.2% [7]. 96% of 
TSH resulted from a trocar diameter of 10mm or greater and 82% of the TSH cases 
occurred in the umbilicus region. Blunt/cutting trocars, trocar type, procedure specificity 
was not found to be related to TSH. Trocar sizes greater than 10mm, failure to suture the 
fascia, fast absorbable suture was found to be linked to TSH. In addition to TSH, 
ineffective trocar suturing can be cumbersome and adds time to the surgical procedure, 
can be intricate, inaccurate, and requires several operators.  
 
Figure 2: Anatomical depiction of an inguinal hernia.[20] 
2.2 Trocar Site Closure Methods 
LAP procedures are increasingly popular in modern medicine. However, even 
with the benefits of LAP surgery, there are technical challenges of properly closing the 
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trocar wound site. Trocar openings dilating the fascial wound to 10mm in adults and 
5mm in children are to be closed, incorporating the peritoneum into the fascial closure, to 
prevent the risk of hernia formation. Closure of these wounds are difficult and not always 
complete due to the small opening of the skin incision. Standard techniques can be 
difficult and frustrating, often involving a blind closure of the fascial defect [9]. Several 
techniques have been developed to facilitate this fascial closure. These techniques vary 
from delivery systems, binding systems, application procedures, and visualization 
techniques. Due to the variety in trocar site closure techniques, each method presents its 
own pros and cons. The sections that follow describe a compilation of trocar site closure 
techniques developed by modern medicine. 
2.1.1 Maciol Needles 
Maciol needles (Figure 3) are a set of three needles used to close a trocar site: a 
straight needle, curved needle, and a retriever needle. The straight and curved needles are 
fed through the abdominal wall into the peritoneal cavity with the suture. The retriever 
needle is inserted into the peritoneal cavity from the other side of the trocar site. Once the 
suture is collected by the retriever needle, the suture is pulled through the tissue under 
direct laparoscopic visualization. The suture is tied within the subcutaneous tissue that 
incorporates the fascia and peritoneum. The suture is inspected before the exclusion of 
the trocar. This procedure does not require any enlargement of the skin incision. 
Contarini et al., studied this closure technique (Core Dynamics Inc., Jacksonville, FL) for 
three years without the reoccurrence of trocar hernia [1].  
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Figure 3: Graphics of Maciol suture in use.[1] 
2.1.2 Grice Needle 
The Grice needle technique includes the passing of one needle from opposite 
sides of the trocar site (Figure 4). First, the Grice needle is inserted at an angle along the 
side of a lateral trocar. Second the suture is passed through the fascia and peritoneum 
cavity. Under direct laparoscopic visualization, the suture is grasped via a surgical 
instrument in an opposite trocar and pulled out of the cavity. The Grice needle is removed 
and reinserted at an angle at the opposite of the trocar to be closed. The suture is grasped 
again and pulled out of the cavity. The trocar is then removed from the patient. The 
suture is tied with added tension placed on the site to prevent the loss of carbon dioxide 
(CO2). Stringer et al. studied this technique (Ideas for Medicine Inc., Clearwater, FL) to 
close 80 lateral trocar sites [2]. 
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Figure 4: Graphics of Grice needles in use.[2] 
2.1.3 Vein Catheter/Spinal Needle 
The technique using vein catheters and spinal needles for suture placement was 
developed after Earle et al and Petrakis et al found a technique for closure with an o-
polypropylene suture applied in a purse-string manner using a 15-gauge spinal cord 
needle (Figure 5). First, a nonabsorbable o-polypropylene suture is inserted with the use 
of a 15-gauge spinal needle 0.5 to 1 cm from the trocar site around the umbilical opening 
at a 45-degree angle, creating a purse string. The first needle is inserted with the suture 
and Endo GraspTM forceps (Medtronic, Minneapolis, MN) are used to pull the free suture 
edge into the abdomen. The needle holding the suture is reinserted at the next point and 
the free intra-abdominal edge of the suture is locked through the loop that had been 
created. This step is repeated three times to correctly orient the purse string. Lastly, the 
suture edge is pulled, and the needle is withdrawn outside the abdomen near the site of 
the first needle insertion, and both edges of the suture are tied up onto the fascia. This 
procedure was studied by Petrakis et al., however, the researchers commented “that this 
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method is not suitable for large abdominal wall defects, complicated hernias, recurrent 
hernias, or routine use to repair anterior abdominal wall defects.” [2] 
 
 
Figure 5: Graphics of Vein Catheter (left) and Spinal Needle (right). [2] 
2.1.4 Endo Close Suture Device 
The Endo CloseTM suture device (Medtronic, Minneapolis, MN) is a spring-
loaded suture carrier (Figure 6). The common technique with this device involves the 
loading of an o-absorbable suture. The suture is introduced to the abdominal cavity 
between the edge of the skin and the port via the Endo Close after which the device is 
removed. The Endo Close is the then injected between the edge of the skin and the port 
opposite to the initial insertion. The suture is reloaded into the Endo Close and the device 
and suture are withdrawn out of the abdomen. The trocar is removed, then the fascia and 




Figure 6: Graphic of the Endo CloseTM suture device in use.[2] 
2.1.5 Gore-Tex Suture Passer 
The Gore-Tex suture passer (W.L. Gore & Associates, Phoenix, AZ) is like the 
Endo Close suture carrier, being a method of inserting and removing a suture from the 
abdominal cavity, but different because it is a reusable device (Figure 7). The Gore-Tex 
device is first loaded with suture and inserted into the abdominal cavity through the 
subcutaneous tissue and fascia on the side of the trocar to be closed (the trocar is still in 
place). The laparoscope is used to view the trocar site to be closed visualizing the 
peritoneal cavity. The suture is released from the grasper by pushing down the handle and 
removed from the cavity. The device is reinserted on the opposite side of the initial 
insertion. The suture is located, placed into the suture passer with the use of graspers in a 
surround trocar, and locked into position by retracting the handle. The suture is removed 
from the cavity by pulling the suture passer out. Lastly, the trocar is removed, and the 




Figure 7: Depiction of the Gore-Tex Suture Passer in use. [2] 
2.1.6 Carter-Thomason Device 
The Carter-Thompson CloseSure System (Cooper Surgical, Trumbull, CT) 
consists of two components: the Pilot guide and the Carter-Thomason suture passer 
(Figure 8). Closure of the incision requires four easy steps. The first step includes using 
the suture passer to push suture material through the pilot guide, fascia, muscle, 
peritoneum, and into the abdominal cavity. The second step is to push the Carter-
Thomason device through the opposite side of the Pilot guide and pick up the suture. The 
third step is to pull the suture up through the peritoneum, muscle, fascia, and guide. The 
fourth step is to remove the Pilot guide and tie the suture. For bariatric and obese patients, 
Carter-Thomason device comes in an extra-long length with a lengthened pilot guide to 
reach the peritoneum layer and provide full-thickness closure. Elashry et al. studied the 
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the CloseSure system and found that it is the fastest trocar wound closure system 
(~11mins) when compared to the Endo Close device and Maciol needles [2]. 
 
 
Figure 8: Depiction of how to use the Carter-Thomason device in use. [2] 
2.1.7 Endo-Judge 
The Endo-JudgeTM (Synergistic Medical Technologies, Inc., Orlando, Florida) 
wound closure device is a 14-gauge hollow J-shaped needle that serves as a carrier for 
suture material and a device for performing the fascial closure (Figure 9). The suture is 
mounted on a reel at the proximal end of the device and fed to the hollow needle until it 
is delivered out the needle tip. The plastic oval shield (olive) at the J portion of the needle 
maintains pneumoperitoneum (keeps the pressure steady in the abdomen) and prevents 
injury to underlaying organs. The instrument is then positioned in a plane perpendicular 
to the trocar incision to expose the needle and pass it through the peritoneum and fascia 
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until it exits the skin incision. The end of the suture is grasped and tagged with a 
hemostat. The needle is dropped back into the olive and rotated to the opposite side. The 
needle is once again passed through the peritoneum and fascia via the olive. After 
removal of the Endo-Judge, the suture is tied creating a secure, airtight fascial and 
peritoneal closure. This device is used under direct visualization. [2] 
 
Figure 9: Step-by-step graphics of how to use the Endo Judge wound closure. [2] 
2.1.8 Tahoe Surgical Instrument Ligature Device 
The Tahoe surgical instrument ligature device (Tahoe Surgical Instruments (San 
Juan, PR) includes a handle with a locking button, one hollow metal needle for delivery 
and one hollow metal needle for retrieval of the suture (both ports are 2 cm apart) (Figure 
10). To use this device, first the laparoscopic cannula needs to be removed. Next the 
suture is loaded into the hollow delivery Tahoe needle without extension beyond the 
distal end of the needle. The device is introduced into the abdomen proceeding the 
insertion of two holes on the introduction disk. The needle tips are then guided to pierce 
the fascia on one side of the trocar site. Releasing the lock allows the handle to depress 
until the metal retrieval loop is extended and encompasses the tip and distal shaft of the 
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delivery needle. The suture is fed into the delivery needle until it lies several inches 
beyond the distal end of the delivery needle and through the retrieval loop. After the 
handle is released allowing the retrieval loop to retract, the entire device is withdrawn 
from the port site. The suture is tied by the surgeon joining the peritoneum and fascia. [2] 
 
Figure 10: Graphic of Tahoe Surgical Instrument Ligature Device. [2] 
2.1.9 eXit Disposable Puncture Closure Device 
The eXit disposable puncture closure device (Progressive Medical, St. Louis, 
MO) is a 10-mm instrument with a recessed right-angle needle manually articulated from 
the proximal end of the device (Figure 11). Due to the size of the device, this instrument 
can only be used in 12-mm trocar ports. The device is inserted into a 12-mm trocar port 
and then needle is exposed for puncture. From the abdominal cavity, the needle is pulled 
up through the fascia and peritoneum. The skin is pulled away from the tip of the needle 
to avoid puncture of the skin. Once the needle is located out of the peritoneum and fascia, 
it is loaded with o-absorbable suture. The device is pushed back through the port of the 
abdomen with the suture. Once in the peritoneum cavity the eXit device is articulated to 
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the opposite side of the trocar. The needle is then pulled up delivering the suture through 
the peritoneum and fascia. The needle is identified, and the suture is pulled out of the 
device. The device is removed from the port, the trocar is removed from the site, and the 
suture is tied closing the post site. [2] 
 
Figure 11: Graphic of eXit Disposable Punture Closure device in use. [2] 
2.1.10 Suture Carrier 
The suture carrier is a hooked device custom designed to maximize vertical space 
when accessing a trocar site for closure (Figure 12). The suture carrier is comprised of a 
hook retractor with an eye drilled into the tip through which suture material can be 
threaded. The instrument designed by Jorge et al. and Li and Chung is 24 cm long has an 
end effector CT needle designed by Ethicon Endo-Surgery. The procedure in using a 
suture carrier starts with lifting the fascial edge vertically with the hook retractor and 
piercing the suture carrier into the peritoneum and fascia of the wound. The suture 
material is threaded into the exposed eye of the carrier. Next, the suture carrier is pulled 
back into the abdominal cavity and pierced through the opposite side of the trocar wound 
site. The suture is collected and tied after the carrier is taken out of the patient. The trocar 
must be removed from the patient before you can perform this procedure. [3] 
16 
 
Figure 12: Graphic of the Suture carrier device in use.[3] 
2.1.11 Lowsley Retractor with Hand Closure 
The Lowsley retractor (Circon ACMI, Stanford, CT) with hand closure is a device 
for trocar site closure for wounds created by 12mm trocars (Figure 13). The Lowsley 
retractor is closed and slid into the intended trocar to the abdominal cavity. Next, the 
blades of the Lowsley device are opened and the trocar is removed from the patient. With 
the retractor still in the abdominal cavity and the blades splayed, the Lowsley retractor is 
pulled upward tilting the fascia towards the skin. A standard hand suture is then 




Figure 13: Graphic of the Lowsley Retractor with Hand Closure in use.[2] 
2.3 Intellectual Property 
A search of US Patents and Patent Applications using the terms “closure” AND 
“trocar” and “bio-absorbable” results in a group of 1000 matches. Another advanced 
search was conducted with the terms “trocar” AND “site” AND “closure” resulting in 
three matches. Below is a compilation of patents that propose a solution to the problem 
statement indicated in this study. The University of Louisville Research Foundation has 
secured a patent on a trocar site closure assembly reserving the intellectual property 
(shown at the bottom of Table 1 this study will build on. 
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Table 1: Table representing the hits for intellectual property search. 
Patent Applications  Title Assignee Pub. Date 
20120316594 Apparatus for closing 
an opening, such as a 
trocar opening, in a 
patient’s body 





closure device and 
method 
Strategic Capital, LLC 4/11/2010 
8323312 Closure device Abbott Laboratories 12/04/2012 





20110144661 Tissue closure 
devices, device and 
systems for delivery, 





6939356 Medical instrument 
for closure of trocar 
site openings and 
method for use of 
same 
Elle G. Debbas 9/06/2005 
9451950 Apparatus and 
method for fascial 
closure device for 
laparoscopic trocar 
port site and surgery 
Manoj B. Patel, Philip 
Zhao, Neal Patel, 
Landon Gilkey, David 
M. Albania, Salvatore 
Castro 
9/27/2016 







2.4 Literature Review Conclusion 
Following laparoscopic surgery, there is a need in many cases to close the trocar 
sites to prevent hernias. Currently, devices that exist on the market are suture based. Lack 
of standardization of suturing techniques, time consuming nature of the procedure, and 
many different techniques to close trocar sites leads to an availability to improve closure 
of trocar sites. Trocar closure sites do not need to be fully closed on the fascial layer, but 
simply blocked at the site where the trocar penetrated the abdominal wall. By sufficiently 
blocking the created opening, post-operative herniation can be significantly reduced. 
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There are complex devices on the market that claim to close trocar incision sites, 
and there are suture techniques that are accepted to seal trocar wounds with cumbersome 
procedures. However, there is yet to be a novel device that combines an easy to use 
device with the reliability to prevent post-operative herniation consistently. In addition, in 
terms of in the realm of intellectual property, there are several opportunities to be 
explored.
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III. METHODS & PROCEDURES
3.1 Device Characteristics 
3.1.1 Specifications 
The device design is a suture-less device that can be inserted through a trocar and 
then engaged into the tissue to block and at least partially close the wound site. Figure 15 
through Figure 20 depicts a progressive conceptual example of a standard delivery 
mechanism for this clip device. The device will be deployed by advancing it through the 
trocar and possesses a flexible design so that the device can compress as it passes through 
the trocar. Once the suture-less device clears the bottom of the trocar, the arms spring 
back (or expand) to its original, non-deformed shape, the device is then pulled up into the 
muscle layer through the peritoneal layer. This device has two arms that engage the 
tissue. Each arm has anywhere from 1 to multiple barbs (2, 3, etc) on either or both sides 
of the arms to retain the device in the tissue while the wound heals. The device design 
can include stress notches on each of the arms to strengthen the device during delivery 
and insertion into the tissue. The device design can include retraction ribs on the outside 
of the arms to increase the retention strength of the clip. Figure 17 and Figure 18 depict 
the deformed and non-deformed state of the closure clip, respectively. This design is a U- 
or V-shaped to allow the arms to be flexible enough to deform through the trocar, and 
durable enough to withstand delivery forces. The tips and/or sides of the arms are 
sharpened to allow the device to tear through the peritoneal and muscle layers, reduce the 
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effects of tissue compliance, minimize the generation of a moment force on the device to 
prevent rotation during delivery, and facilitate the delivery of the device.  The angular 
design of the barbs prevents dislocation of the device by gripping the tissue to prevent 
motion of the device post delivery. The devices are made of biodegradable material that 
will degrade as the patient heals. The porosity of the material (infill) may vary to 
decrease the rate of material biodegradation. The tool used to insert and deliver the trocar 
site closure clip can be unique to the trocar clip design or universal to fit in all endoscopic 
forceps. The release of the trocar site closure clip can be by torqueing, manually 
releasing, or snapping off the trocar site closure clip of the delivery tool. Figure 14 
depicts a CAD model of a potential trocar site closure clip. 
  
Figure 14: Solidworks Model renderings of the laser-cut device (left) and Post-processed device (right). 
 
3.1.2 Device Delivery Concept 
The order of operation for deploying the device is illustrated in Figure 15 through Figure 
20, and includes the following steps:  
1. Insertion of distal end of device into the proximal end of the trocar. 
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2. Application of axial force on the device, compressing the arms of the trocar site 
closure clip into the trocar. 
3. Passing of the clip through the trocar into the abdominal cavity. 
4. Rebound of the clip arms to the original uncompressed/non-deformed span. 
5. Removal of the trocar from the patient. 
6. Retraction and delivery of the trocar site closure clip to plug the trocar opening. 
7. Snap or manual release of the trocar site closure clip from the delivery device.  
 
Figure 15: Insertion of the distal end of the TSCC into the proximal end of the trocar. 
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Figure 16: Passing of the clip through the trocar into the abdominal cavity. 
 
 
Figure 17: Removal of the trocar from the abdomen of the cavity. 
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Figure 18: Retraction and delivery of the TSCC to plug the trocar opening. 
 
 
Figure 19: Remnant of device after the TSCC stem is snapped/broken off and excised. 
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Figure 20: Bottom view of plugged trocar site. 
3.2 Device Manufacturing Processes 
3.2.1 Design Analysis of Distal Stem 
A five design DOE was conducted with various end effectors and distal designs to 
optimize the distal design of the device to ability minimize the insertion force and 
deformation through the trocar and minimize the required force and device deformation 
during delivery (piercing) into the tissue. Five solid model configurations of the distal 
design were created in computer aided design (CAD) software (SolidWorks, Dassault 
Systèmes, Waltham, MA) using varying angles, notches, and narrowness (Figure 21 and 
Figure 22). Two thicknesses of the ABS devices (1/8” and 1/16”) were used for 
comparison. A full factorial study with three factors (design, thickness, and tube 
delivery), factors levels at five designs, two thicknesses and two tube delivery methods, 
along with three replicates requires a total of 60 data points. A random run order was 
utilized to account for device variance. Devices were constrained by an applicator at the 
two holes in the proximal stem of the device.  
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Figure 21: Different end effector designs for final design selection of ABS TSCC. 
 
Figure 22: CAD model of Design 3. 
3.2.1.1 Laser Cutter Configuration 
The solid CAD model designs were transferred to an image to (Adobe Illustrator, 
For Web and Interactive Design, Ventura CA) cut the design onto a sheet of material. For 
cost effectiveness, the design study was conducted on acrylonitrile butadiene styrene 
(ABS), a material that is similar in tensile properties to PLA, but cheaper and easier to 
obtain. Devices were laser cut on a BOSS laser cutter (model: LS1630, BOSS Laser, 
LLC, Sanford, FL, Figure 22) and labeled for testing. For cutting, the laser cutter was 
programmed to cut at 20mm/s at 20% power. The laser was passed twice over the ABS 
sheets to ensure a clean cut of the devices. Figure 24 through Figure 29 show the general 
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workflow for fabricating the ABS test devices: 1) 36in by 12in sheet of ABS was placed 
in the laser cutter; 2) 60 devices were cut with the laser at the operating parameters stated 
above; and, 3) finished cut devices were removed from the laser cutter, separated and 
packaged based on the design and thickness of the devices. 
 
Figure 23: Laser Cutter used for device preparation. 
 
Figure 24: ABS Sheet laid in laser cutter. 
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Figure 25: ABS devices being cut from ABS sheet by laser cutter. 
 
 
Figure 26: Finished printed TSCC from laser cutter. 
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Figure 27: Finished 1/8” devices packaged and ready for testing. 
 
 
Figure 28: Device applicator (top) and secured TSCC in device applicator (bottom). 
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Figure 29: Line up of TSCC and proximal end of Trocar prior to testing. 
The tube delivery method describes the fixtures that were used to insert and 
deliver the devices and the speed at which the devices were delivered into the tissue. The 
two speeds (tube delivery) used in this study were 1in/min and 2 in/min.   
Devices will follow the order of operation described in 3.1.3 until delivery of the 
device onto an acrylic plate. The devices will not be tested for retraction force or the 
force to separate the distal end of the device from the proximal stem. A fixture was 








3.2.2 Initial Device Manufacturing Process 
The manufacturing process of this device started with the fused filament (3D) 
printing of the material. The material used in the cadaver studies was an Ecomax® PLA 
(polylactic acid) biodegradable co-polymer (3DXTech, Grand Rapids, MI) using 100% 
virgin PLA biopolymer resin and colorants. A M2 Makerbot (MarkForged, Brooklyn, 
NY) fused deposition modeling (FDM) printer was used to extrude an 1/8” plate of PLA 
to fit four devices. The PLA was printed using 100% infill which ensures a solid device. 
The pre-sharpened device CAD design was downloaded and then laser cut (BOSS LS-
1630) in the PLA sheet printed in the fused filament printer using the same operating 
parameters as described above for the ABS devices. The pre-sharpened devices were then 
sharpened in a custom guillotine fixture (Figure 30). 
 
Figure 30: Process for further sharpening the tips of the device arms (left to right). 
3.2.2.1 Guillotine Sharpening Method 
Devices were placed in the bottom half of the fixture and a razor was placed in the 
top half of the fixture to create a “guillotine” type tool. The bottom half and top half of 
the sharpening fixture were aligned by dowel pins to drop the “guillotine” at the same 
location every time. The top half of the fixture was then pressed onto the TSCC mounted 
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in the bottom half of the fixture to cut angled corners off the TSCC arms. Once, one side 
of the device arm was cut, the device was flipped and cut again using the same process 
described above leaving sharpened tips on the device arm. 
3.2.3 Modified Device/Delivery Concept 
The original device delivery concept was modified from a torsional, snap-off 
release concept to the utilization of a separate tool to manually release the device after 
being delivered into tissue. Figure 31 illustrates the modified device delivery process 
utilizing the separate tool to deliver and release the TSCC device. This separate tool 
should have a long shaft length of 8in and a diameter of less than 10 mm. The tip of this 
tool should have a pattern on the ed effector to initiate some sort of grip on the device. 
 
Figure 31: Schematic illustrating the insertion of the trocar into the abdominal cavity. 
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Figure 32: Schematic illustrating the compression of the device as it translates through the trocar. 
   
Figure 33: Schematic for illustrating the steps for removal of the trocar and retraction of the device into the 




Figure 34: Schematic illustrating the release of the TSCC into the abdominal cavity to obstruct the opening. 
 
3.2.3.1 Final Device Manufacturing/Delivery Process: 
 
Figure 35: Laser cut devices (right) from FDM printed sheets (left) of PLA. 
1/8” thick sheet of PLA 
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Figure 36: Schematic illustrating the guillotine fixture for sharpening tips of the new device arms. 
  
Figure 37: Image of the Dremel tool (left) used to taper the arms of the device (right). 








Figure 39: Images of the heating and stamping of the device stem to fix device into the endoscopic forceps. 
Top left: heat gun; Top right: heating of the device stem; Bottom: final device placed in endoscope forceps. 
Concentration of heat 




Figure 40: Final sharpening with grade P1600 sand paper of device arms: Top left: before 
sanding; Top right: sanding process; and, Bottom: finished device. 
 
The manufacturing process ( Figure 35 through Figure 40Error! Reference 
source not found.) of the final TSCC device started similarly to the previous method, 
that is, 100% virgin Ecomax® PLA  biopolymer resin and colorants were used to 3D 
print extrude an 1/8” plate of PLA using the M2 Makerbot FDM printer. However, this 
Sharpened to be normal to tissue 
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time the PLA was printed using 95% infill. The pre-sharpened device CAD design was 
downloaded and then laser cut (BOSS LS-1630) from the printed PLA sheet using the 
same operating parameters as defined above (20mm/s at 20% power). The pre-sharpened 
devices were inserted into the custom guillotine fixture to sharpen the tips of the device 
arms. The device arms were then tapered with a Dremel tool (Dremel Tools, Racine, 
WA) to give a triangular shape – the sharpened tip of the devices was maintained during 
this step. Subsequently, the arms were sanded down with two different grades of 
sandpaper (220-grade and 1600 grade) to decrease the surface roughness. After the 
device arms were sanded down to a smooth finish, the stem of the device was heated 
(using a heat gun Atten Instruments, 85OB) and the end effector pattern of the 
endoscopic forceps was stamped onto the stem of the device. A nozzle was used on the 
end of the heat gun to concentrate the heat on the stem of the TSCC. The heat gun was set 
to a temperature of 310 ºF and a blow setting of 4. The heat gun was passed over the stem 
at a distance of 1 inch from the TSCC device surface, twice. After stamping the devices, 
they were submerged in a beaker of cold water to set the mold of the TSCC design. 
Lastly, the 1600 grit sandpaper (3M) was used to give a vertical point to the device to 
improve the piercing ability of the TSCC device for tissue penetration (Figure 40). It is 
noted that the manufacturing process of the prototypes was constrained due to the 
availability of tools. This process could be greatly enhanced using more sophisticated 
manufacturing processes, such as injection molding, and a custom sharpening device that 





3.3 Benchtop Studies 
3.3.1 Materials Testing System Set-up 
A materials testing system (MTS, MtestQuatro, Norwood, MA) was used to 
measure the vertical forces exerted on the device as it is lowered into the trocar and as the 
device is pulled upward to be delivered into the tissue (Figure 42). Measurements of the 
insertion force and delivery force will be recorded as peak values by the MTS. The MTS 
was programmed with a data sampling rate of 100 Hz and recorded both the position and 
load force as a function to time. 100Hz was calculated using the Nyquist theory of 
sampling. To accurately plot the data it was estimated that 50 data points per second of 
load frame movement would be needed. Nyquist theory states that the frequency used to 
measure should be 2x Fmax. Therefore 100 Hz was used to plot the data points. 100 lbf 
load cell was used to accurately measure the tensile forces. Devices were lowered and 
raised at a rate of 1in/min and 2 in/min to the desired distance to pass through the trocar 
and penetrate through the medium being tested. In this case, the medium being tested was 
chicken breast tissue. The chicken breasts were held down with the equal displacement of 
the normal force. Figure 41 shows the set-up of the load frame with the mount used to 
orient and stabilize the trocar. The chicken breasts were held in place by Plexiglas® 
around the edges. The Plexiglas® was constrained to the mount by clamps/screws. 
Screenshots of the MtestQuatro software is in the appendix section 6.1. 
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Figure 41: Image of the MTS load frame set-up used for testing the TSCC devices. 
3.3.2 PLA Material/Printer Study 
The purpose of this test is to compare PLA materials/printer settings to determine 
the difference in PLA prototype performance to be used in animal and cadaver studies. 
The two PLA filaments compared in this study are: 1) the PLA devices used by Dakota 
Waldecker (my predecessor) in his cadaver studies; and, 2) the PLA devices used in this 
study on cadavers. It was necessary to test this change in PLA manufacturing because the 





Plates to hold the chicken 
breast while delivering the 
device. 
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work. Therefore, a new PLA filament and printer was compared to the previous PLA 
devices to determine any differences in PLA peak failure points and assess whether there 
were significant differences between the two prototypes. In this study, two PLA types 
were compared in their ability to withstand a tensile force on the arms of the device. A 
total of nine devices were tested from each manufacturing system.  
The PLA devices used in the Cadaver Lab 1 studies were printed at Advanced 
Solutions Inc. using a M2 MakerGear FDM printer (Beachwood, OH). The devices used 
in this study were 100% infill in a 45° rectilinear pattern with a first layer extrusion 
temperature of 215°F and 210°F for the subsequent layers. The bed temperature for the 
first layer was 65°F and 60°F for the subsequent layers. The program used to splice the 
design was a Repetier-Host (version 1.2.9, BoXYZ, Pittsburgh, PA). Screen shots of the 
PLA printer settings can be found in the appendix section 6.2 of this document. 
A dowel pin inserted through the proximal slot of the device stem constrained the 
device to the load frame. The load frame depicted in Figure 42 shows the fixture that 
holds the dowel pin in place while the load frame pulls the device upward. TSCC devices 
were compared by the peak tensile force that plastically deformed the device in tension. 
The two materials were tested to determine if there was a statistical difference in the 
material properties between the two materials used. Laser cutting of the devices followed 
the parameters in 3.2.2 on the PLA sheets.  The load frame set up followed the 
parameters described in 3.3.1. The load frame head speed was 2 in/min for the upward 
motion of the device.  
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Figure 42: Test set-up for peak tensile force (constrained by dowel pin). 
 
 
Figure 43: Before (left) and after (right) tensile force applied to determine plastic deformation peak force. 
3.3.3 Infill Study 
In this study, device infill was adjusted to increase the ductility of material to 
increase the flexibility of the device and decrease the force required to insert device into 
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the trocar. In addition, it was predicted that decreasing the infill and having a more 
porous PLA device would decrease the time for biodegradation and create pockets for 
tissue integration. The stiffness of the initial design created stress marks at the notches 
indicating that compression of the arms plastically deformed the device (Figure 44) and 
led to device failure during delivery of the device into the medium.  
  
Figure 44: Depiction of the plastic deformation at the distal end from insertion into the trocar. Arrows 
indicate sites of stress and eventual failure of the devices. 
 
Devices were altered to have 70%, 80%, 90%, and 100% infill during the FDM 
printing process of the PLA sheets. This alteration was intended to increase the flexibility 
of the device arms upon insertion into the trocar. The same FDM printer settings as 
referenced in appendix 6.2 were used, but the infill of the PLA sheets was changed to 
70%, 80%, 90%, and 100%. The laser cutter and load frame settings were the same as 




Figure 45: Images of the PLA sheet cut-outs for the varying infill settings 
(top left: 70%, top right: 80%, bottom left: 90%, bottom right: 100%). 
A design of experiments was created with 1 factor, 4 levels, 3 replicates, and 2 
responses. The 4 levels to the infill factor were 70%, 80%, 90%, and 100% and the two 
responses were insertion force and delivery force. The responses were utilized to create a 
linear regression analysis for the optimal device infill. Comparisons were conducted in 
random order fashion to account for the variability of the testing procedure. Devices were 
inserted into a 12mm trocar to simulate the trocar that the device will be inserted during 
the cadaver lab. Devices were retracted into the Plexiglas® platform similar to the 
delivery test conducted in 3.2.2 with the same insertion rate and data acquisition settings. 
Figure 46 depicts the test fixture set-up for testing (similar to the testing conducted for 
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the design and material study 3.2.1 and 3.3.2, respectively). The devices were constrained 
by two set screws at the proximal stem. 
  
Figure 46: Test Set-up for PLA infill study. 
3.3.4 Sharpening and Acetone Study 
This study was conducted to mitigate proximal stem stress deformation upon 
insertion into a trocar and the problem of high delivery force required to penetrate tissue. 
Device sharpening was required for the penetration of the device into the fascia of the 
tissue. A blunt tip on the arms of the device increases the force required to penetrate 
tissue and increase the force on the arms of the device. Therefore, a fixture was created to 
sharpen the arm tips on the devices to improve tissue penetration and relieve the force on 
the device arms. 
In addition, devices were treated in acetone to increase the flexibility of the device 
arms for easier insertion into the trocar. It is a known technique to rub acetone on PLA 
FDM printed part to soften the material. In this study, acetone was used to soften the 
device arms for increased flexibility. 
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The purpose of this study was to test the sharping fixture and the acetone 
treatment for effectiveness in device insertion and device penetration. 
The tissue models used in this study will include the Dragon Skin silicone and 
Chicken thigh. Silicone materials have been used to simulate tissue biomechanics as 
related to deep tissue injury [12]. Chicken thigh was used because of its use in the design 
study: section 3.2.1. 
This study included a three factor DOE with two factor levels, and 12 replicates. 
Using the data from the previous studies, power analysis estimated that 12 replicates 
would be needed to achieve a power greater than 90%. The responses recorded included 
insertion force and delivery force. 
• Sharpening 
o Sharpened 
o Not Sharpened 
• InFill Pattern 
o 95% Rectilinear (Acetone Treatment) 
o 95% Rectilinear (No Acetone Treatment) 
• Tissue Model 
o Dragon Skin 
o Chicken 
PLA with 95% infill was used in this study because of its positive results from the 
infill testing (referenced in section 4.2.1). Device manufacturing followed the same steps 
outlined in study 3.2.2 in terms of device PLA printing and laser cutting. Device were 
47 
then treated with a drop of acetone at the arms of the device as pictured in Figure 47 then 
left overnight to dry. 
 
Figure 47: Drops of acetone on arms of the device to soften the PLA material. 
Following laser cutting, devices were sharpened by the fixture depicted in Figure 
36. Dimensions of the sharpening fixture can be found in Appendix section 6.3. 
3.3.4.1 Application Fixture 
The application device in Figure 48 was created for cadaver testing. The 
aluminum applicator has tapped hole at the proximal end that is compatible with a hand-
held force gauge. The distal end of the device mimics the proximal shape of the device so 
that the device can be constrained. The distal holes were tapped to allow set screws to 
hold the TSCC in place. Dimensions of the applicator can be found in the Appendix 
section 6.4. Dragon skin silicone was cut to have an incision large enough to fit the 
trocar. The load frame mount to stabilize/orient the trocar was updated to be compatible 
in constraining both dragon skin and chicken thigh (Figure 51 and Figure 52). 
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Figure 48: Expanded view of application device and TSCC assembly. 
 
Figure 49: Application device in upright stance. 
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Figure 50: Small Incision made in Silicon for Trocar insertion. 
  
Figure 51: Visual of test set-up before (top) and after (bottom) of trocar in and out of test fixture. 
Load frame and device laser cutting were conducted as described in sections 3.3.1 
and 3.2.2. The test fixture to constrain the tissue models followed the layout in study 
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3.3.1.  However, for this study, clamps were added to the second tier to constrain the 
tissue models: chicken thigh and dragon skin silicon (Figure 52). 
 
Figure 52: Devices sharpening and infill test fixture. 
3.3.4.2 Dragon Skin Silicone Preparation: 
The Dragon Skin Silicone was prepared to the specifications included in the 
package. The dragon skin silicone utilized is the Smooth On: Dragon Skin Translucent 
Platinum Silicone (Smooth On Inc., Macungie, PA). Figure 53 through Figure 56 show 
the process used to set the dragon skin silicone evenly and to the same depth. Plastic petri 






the wet dragon skin silicone to ensure consistency between batches. The silicone discs 
were cut into quarters for use in testing. 
   
Figure 53: Separation of ingredients in two cups. 
   
Figure 54: Weighing of mixture components (left and middle) and mixing of components in fume hood 
(right). 
   
Figure 55: Measurement of petri dishes and pouring silicone into petri dishes. 
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Figure 56: Allowing the silicone to dry in petri dish before cutting the specimen into quarters. 
3.3.5 Revised Device Application Study 
In evaluation of the devices during the cadaver testing, there was a necessary 
adjustment needing to be made to the design of the device. The applicator was updated to 
another model requiring a more rigid structure and holding the device at a more distal 
position. The new application device was planned to be used with an updated TSCC 
design. To hold the TSCC at a more distal point, the stem of the device was taken off. In 
addition, it was predicted that narrower arm stems would be needed to decrease the force 
required to deliver the TSCC into tissue. Lastly, to fit the new application device, 
Snowden-Pence lap tool, the TSCC were heated and stamped to merge the design of the 
Snowden-Pence applicator end effector to the proximal end of the TSCC. Figure 31 
through Figure 34 depict the updated manufacturing steps to create the TSCC. 
The methods of this study consisted of functional trials using the device prototype 
to plug trocar site sized incisions in dragon skin silicon and porcine belly. A full factorial 
design was created with two factors (material treatment and tissue model), two levels, 
with five replicates. The levels in this study included two different materials: PLA with 
acetone dip or PLA without acetone dip and two different tissue models: dragon skin 
silicone or porcine belly. Porcine belly squares prepared by a butcher was used in this 
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study as the second tissue model (Kingsley Meat and Catering, Louisville, KY). The 
porcine belly was positioned to be penetrated from the skin side to model, being a more 
rigid surface to penetrate. PLA devices were treated with acetone like the acetone treated 
devices in 3.3.4. The dragon skin silicone was prepared as described in section 3.3.4.2. 
The responses test in this study were the insertion force (the peak force required 
to pass the device into the trocar, the delivery force (the peak force required to insert the 
device into the medium), and the retention force (the peak force withstood in attempts to 
dislodge the device out of the medium). The same load frame set-up was used from study 
3.3.4 with the same sampling rate and load frame insertion/delivery rates. However, 
instead of using clamps to constrain the tissue model as performed in 3.3.4, a new 
Plexiglas® plate was used to constrain the tissue model. This change was made to 
simulate a more diffused surface force when holding the tissue models in place (shown in 
Figure 59). From this study the best prototype will be selected and utilized in another 
cadaver lab to prove efficacy of the design. Cadaver lab was conducted in the Fresh tissue 
lab at the University of Louisville Medical School with Dr. Daniel Metzinger. 
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Figure 57: Acetone treated devices drying. 
 




Figure 59: Delivery of updated TSCC devices into porcine belly squares. 
3.4 Cadaver Studies 
3.4.1 Cadaver 1 Study 
The purpose of this study is to evaluate the ability of TSCC in sealing a 12mm 
trocar wounds in a cadaver. Cadaver tissue is to be an indicator of the effectiveness of the 
TSCC to penetrate living tissue. This study is an indicator of whether the TSCC is ready 
for further testing in chronic animal testing. Cadaver tissue is known to be less elastic 
than live tissue, so the cadaver tissue is meant to simulate a scenario that is harder to 
penetrate. 
The cadaver was ordered through the University of Louisville Bioengineering 
department. The study was conducted at the University of Louisville School of Medicine 
in the fresh tissue lab. During this study the force to insert the TSCC and deliver the 
Plexiglass plate pressed 
onto tissue to secure in 
place during device 
delivery.  
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TSCC was measured with a hand-held tensile force gauge and a custom application 
device shown in Figure 60. 
         
Figure 60: The attachment of the applicator to the hand-held force gauge. 
The updated and current design for the TSCC was compared to the past TSCC 
that were created in previous studies. The goal of the testing to demonstrate an 
improvement from the previous cadaver testing to show a decrease in force required to 
insert the TSCC into the trocar and the force required to deliver the TSCC into the tissue 
when compared to the previous design. Six of the previous devices were used in the study 
and six of the newly developed prototypes were tested in this study. The newly developed 
devices in this study were the 95% infill with acetone, sharpened devices tested in 3.3.4. 
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3.4.2 Cadaver 2 Study 
The purpose of this study is to evaluate the ability of TSCC in sealing a 12mm 
trocar wounds in a cadaver. Cadaver tissue is to be an indicator of the effectiveness of the 
TSCC to penetrate living tissue. This study is an indicator of whether the TSCC is ready 
for further testing in chronic animal testing. Cadaver tissue is known to be less elastic 
than live tissue, so the cadaver tissue is meant to simulate a scenario that is harder to 
penetrate. 
The cadaver was ordered through the University of Louisville bioengineering 
department. The study was conducted at the University of Louisville School of Medicine 
in the fresh tissue lab. During this study the force to insert the TSCC and deliver the 
TSCC was measured with a hand-held tensile force gauge and a custom application 
device. 
This study was like the study conducted in 3.4.1 in terms of device preparation 
and the programing of the load frame. However, a new updated TSCC design was 
utilized as tested in 3.3.5. In this cadaver study a two factor DOE was conducted with 
two factor levels, and four replicates. The factors in this study was either a one barb 
design or a two-barb design, and if the TSCC devices were treated in acetone or not 
treated in acetone. Devices were inserted with the new application device as tested in 




Figure 61: Snowden-Pence Lap Tool Applicator. 
 
Figure 62: Clamp placed onto Snowden-Pence Lap Tool. 
 
 
Figure 63: Attachment of clamp to hand-held force gauge depicting entire set-up for cadaver testing. 
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3.5 Short Chronic Animal Study 
3.5.1 IACUC Proposal Methods 
The purpose of this study is to evaluate the ability of TSCC in sealing a 12mm 
trocar wounds and to analyze the healing progression of tissue around the inserted device. 
For this study three 60kg pigs were ordered and tested under local anesthesia in the RRC 
at the University of Louisville hospital at different times. The IACUC test proposal can 
be found in the Appendix section 6.5 including the proposed test procedure, anesthesia 
protocol, and (pain management) protocol. The tested pigs were kept alive for seven days 
prior to euthanasian. Porcine tissue is to be an indicator of the effectiveness of the TSCC 
to penetrate living tissue and predictive of healing progression around the device in 
human tissue. This study is meant to provide proof of concept for the TSCC in effectively 
plugging, sealing trocar wounds, and preventing postoperative herniation. The animals 
were ordered through the University of Louisville bioengineering department. The study 
was conducted at the University of Louisville RRC along with help from trained IACUC 
veterinarians and technicians. During this study the force to insert the TSCC and deliver 
the TSCC was not measured with a hand-held tensile force gauge. The main objective of 
this study was to examine the healing progression of the TSCC device in a living model. 
In this study, the sharpened, no acetone dip, one barb TSCC design was utilized 
as tested in 3.5.1. Due to the success of the one barb TSCC design in cadaver lab 2, and 
since retention force was not going to be measured, there was no need to test more than 
one TSCC design. A total of six trocar incisions were created in each pig and six devices 
were delivered in each pig. Devices were inserted with the new application device, 
Axillent Lap Tool (Karl Storz, Tuttlingen, Germany), tested in 3.4.2. The only difference 
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of this applicator is the distal grip design and proximal release mechanism. This change 
was to make testing easier for the surgeon. All the pigs were not tested on the same day 
and each pig did not receive TSCC from the same batch. A new batch of devices were 
created for each pig study. TSCC was sterilized prior to testing via ETO sterilization at 
the RRC. Before the chronic animal trials were conducted, test trials were prepared with a 
recycled rabbit carcass from another study. The rabbit was euthanized just before this 
trial run and a couple of TSCC devices were delivered into the tissue without any issues. 
Figure 64 through Figure 66 show images from this trial test setup. 
 
Figure 64: Trial of TSCC on Rabbit Carcass with Axillent Karl Storz Lap Tool Applicator. 
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Figure 65: Picture of abdominal wall from the outside of carcass after device was inserted. 
 
Figure 66: After closing the trocar wound with TSCC device in trial carcass. 
3.5.2 Histology Preparation 
Seven days after the procedure, the animals were euthanized, and the trocar sites 
were harvested and set in formaldehyde. The harvested devices were shipped to Mass 
Histology in Worcester, MA for histology of the trocar sites. All sites, whether they were 
successfully plugged, or open wounds were sent for histology. The services requested 
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include slide preparation from tissue equally spaced from the axis of the trocar wound, 
trichrome staining, a semi-qualitative report analyzing for newly formed collagen fibers, 
and annotated photography showing new collagen formation of tissue near implanted 
device in container. The goal of the histology was to help analyze/compare the presence 
of new collagen fibers near the incision site, the implanted device, around the healing 
wound, and to get an impression of the device biocompatibility in an animal.  
A 2017 publication studying The Biodegradation and Biocompatibility of Poly L-
lactic Acid (PLLA) implantable Mesh performed an in vitro and in vivo 180-day 
evaluation of alterations in weight, tensile strength, inflammatory response. The study 
found that “the weight and tensile strength of the PLLA prosthesis was stable for 180 
days. In addition, the surface of the PLLA mesh was not digested under in vitro or in vivo 
conditions as determined by scanning electron microscope. Histologically, there were no 
significant changes in the diameters of implanted PLLA mesh and subtype fibers over the 
course of 180 days. Likewise, there were no significant changes in the number of 
inflammatory and mast cells after 180 days, nor was there an increase in the percentage 
of collagen surrounding the PLLA mesh” [13]. Results indicated that PLLA mesh did not 
induce inflammation in subcutaneous tissue; however, according to other literature, may 
induce inflammation in different tissues or under specific incubation conditions. The goal 
is for this study’s histological findings to determine the biocompatibility of PLA (from 
this study) in peritoneal tissue.
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IV. RESULTS AND DISSCUSSION
4.1 Design Results 
4.1.1 Device Distal Stem Design Results 
This study was conducted to determine the distal end effector design that is most 
effective for parameters laid out for the TSCC in Section 3.1. The goal was to find the 
distal design that requires the lowest insertion force and the design that can withstand the 
highest delivery force. The results of this study show that there were significant 
differences between the designs and thicknesses during the insertion of the devices into 
the 12mm trocar, but no significant difference caused by the interactions of the factors, as 
seen in Figure 67. The main effects were plotted for insertion forces of the devices and 
designs 1, 2, 3, 4, 5 had an average insertion force of 2.06lbs, 2.84lbs, 1.65lbs, 1.79lbs, 
and 2.29lbs respectively. The Tukey pairwise comparisons are shown in Figure 69. From 
the Tukey pairwise comparison it can be determined that designs 2 and 5 had a 
significantly higher insertion force and designs 1, 4, 3, had a significantly lower insertion 
force also shown by the main effects plot in Figure 68. Thickness of 1/16” had an average 
insertion force of 1.66lbs, and thickness of 1/8” had an insertion force of 2.600lbs.  
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Figure 67: Analysis of Variance in Insertion Force. 
 
Figure 68: Main Effects Plot of Insertion Force. 
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Figure 69: Tukey Pairwise Comparison of Insertion Force. 
In addition, the results of this study show that there were significant differences in 
delivery force caused by the thickness of the designs and by the interactions between the 
design, thickness, and tube delivery system as seen in Figure 70. The delivery force 
interaction plot in Figure 71 shows that devices with a thickness of 1/8” can withstand a 
significantly higher delivery force. The delivery forces for designs 1, 2, 3, 4, 5 at 
thickness of 1/8” and tube delivery 1 had an average of 17.24lbs, 15.94lbs, 34.70lbs, 
29.30lbs, 18.32lbs respectively. The Tukey pairwise comparisons are shown in Figure 72. 
From that chart it can be determined which group of devices had the highest delivery 
forces under which interactions. It is also shown that for designs 4, 1, and 5, the tube 
delivery method did not have a significant effect on delivery force. High delivery force 
means that the design can withstand more force and is a more superior design compared 
to the others. This can be emphasized by the fact that the design changes are only 
applicable to the end effectors and not the device arms. 
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Figure 70: Analysis of Variance of Delivery Force. 
 
Figure 71: Interaction Plot of Delivery Force. 
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Figure 72: Tukey Pairwise Comparison of Delivery Force. 
To distinguish the most effective design for the purposes of this application, a 
decision matrix was created as seen in Table 2. This decision matrix was used to rank the 
TSCC designs by their insertion force averages, delivery force averages, and the ease of 
testing. The delivery force averages were weighted higher than the insertion force, and 
the insertion force averages were weighted higher than the ease of testing. Each category 
of the decision matrix was given a number to rank its performance in testing. The higher 
the number, the more desired the result. In this case, lower insertion forces were desired 
and higher delivery forces were desired. The tube delivery 2 was more preferred than 
tube delivery 1 because of the less time required in testing. The distal design of device 4 
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led to showing that the design was capable to withstand the highest delivery force while 
minimizing the force required to insert the device into the trocar. The other distal designs 
did not show this trend to the extent that design for did. After totaling the results, design 
4 at 1/8” was selected to be used in further studies. 
Table 2: Decision Matrix for Optimal End Effector TSCC Design. 
 
4.1.2 Dakota Prototype Material Study 
Summaries for the results of the two devices tested can be found in Figure 73 and 
Figure 74. For the results of this study a non-normal, Kruskal Wallis test (Figure 75) 
performed after unsuccessful attempts to transform the non-normal data from both 
materials. The transformation used include: sqrt(t); 1/sqrt(1); ln(y); log10(y). In 
comparison of the two PLA materials, the ECOMAX PLA and the PLA material used by 
the previous student differed in their peak tensile forces. The average peak break force of 
the Advanced Solution devices was 24.9lbs (Figure 73) and the average peak break force 
of the ECOMAX devices was 20.62lbs (Figure 74). Even though the testing shows that 
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there is a significant difference in the peak forces of these two PLA materials, the 
ECOMAX devices are still an applicable choice. The ECOMAX devices having a 
maximum peak load of 20.62lbs should be more than enough for the requirement of our 
devices. For clinical circumstances, the devices should need no more than 10lbs force for 
the device to be delivered into tissue. Since the ECOMAX devices had a peak force of 
two times what should be necessary, it can be considered a viable candidate for 
prototyping.  
 
Figure 73: Summary of Advanced Solutions Devices. 
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Figure 74: Summary of ECOMAX devices. 
 
Figure 75: Kruskal-Wallis Test for Material Study. 
 
4.2 Benchtop Studies Results 
4.2.1 Infill Study 
The goal of this study was to optimize the infill percentage of the devices to have 
the most effective insertion forces while not compromising the delivery force tensile 
strength. The 70%, 80%, and 90% devices broke upon insertion into the trocar. The 
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devices were too fragile to make it into the trocar without fracturing inside. Figure 76 
shows the failure of a device after insertion into a trocar.  
  
Figure 76: Fracture of the left? device arm. 
The 100% infill devices were the only devices that made it through the trocar 
intact, however, the devices had stress notches on the distal end. The devices were 
compromised by the stress notches and the delivery device force varied between runs. 
Figure 78 and Figure 79 shows end of the delivery force test and the breakage of the 
other infill devices. Due to the variability of the 100% devices and the failure of the 70%, 
80%, 90% devices failed during insertion, a linear regression couldn’t be made. 
Therefore, a fifth infill percentage was created and tested at 95% infill. Figure 77 shows 
the results for testing with the 95% infill. Tensile forces for 70%, 80%, and 90% are the 
tensile break forces.  The 95% infill devices didn’t always show signs of stress notches 
forming on the distal end due to the compression of the device arms when passing 
through the trocar. The delivery force of the 95% devices were more consistent and 
showed less sign of device stress.  
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Figure 77: Bar Plot of Insertion Force and Delivery Force in PLA Infill Study. 
 


























95% CI for the Mean
Individual standard deviations are used to calculate the intervals.
Some 100 Infill Devices Broke
Infill Results Bar Chart
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Figure 79: Device Tensile Force Break Point Testing. 
4.2.2 Sharpening and Acetone Study 
The results of the benchtop study comparing acetone treatment to non-acetone 
treatment along with a comparison of tissue models are shown as a Bar plot in Figure 80. 
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Figure 80: Bar Plot from Benchtop Testing of Acetone/Non-Acetone treated devices in both tissue models. 
In the bar plot in Figure 80, the Acetone 1 refers to devices that did have the 
acetone treatment, and Acetone 2 refers to devices that did not have the acetone 
treatment. Tissue model 1 refers to delivery of the devices into the dragon silicone, and 
Tissue model 2 refers to delivery of the devices into the chicken thigh. The devices that 
were not treated with acetone plastically deformed during insertion into the trocar and 
were compromised before being delivered into the tissue model. Due to this, the non- 
acetone treated devices never pierced the silicone and the arms snapped off. The acetone 
treated devices had a lower insertion force than the non-acetone devices. During 
insertion, the acetone treated devices were able to flex and did not fracture during 
insertion into the trocar. The allowed the acetone treated devices to remain intact and 
maintain the structural integrity pierce through the silicone. Both the non-treated and 



































95% CI for the Mean
Individual standard deviations are used to calculate the intervals.
No Acetone Devices Did Not Penetrate Silicone
Sharp v. Acetone Results Bar Chart
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treated devices were selected to be used in the cadaver lab. Averages for the benchtop 
testing are labeled in Figure 80. Pictures from testing are shown in Figure 81 through 
Figure 84. 
  
Figure 81: Acetone treated devices piercing the dragon skin silicone during testing. 
 








Figure 84: Devices laid out prior to testing. 
 
4.2.3 Revised Device Application Study 
In this study, both acetone-treated and non-acetone treated, were evaluated in 
dragon skin silicone and porcine belly, respectively. The non-acetone treated PLA 
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devices required an average of 2.7lbs insertion force to pass into the trocar, and a 6.46lbs 
delivery force to pierce into dragon skin and an 8.67lbs delivery force to pierce into the 
porcine belly (Figure 86 and Figure 87). The acetone treated PLA devices failed during 
the delivery process into both the dragon skin and porcine belly tissue models with an 
average failure force of 5.76lbs and 9.7lbs, respectively. Therefore, only the non-acetone 
treated PLA devices were used in the cadaver lab to prove the efficacy of the devices. 
Figure 87 and Figure 88 show the failure of an acetone device failing in dragon skin 
silicone and a successful non-acetone device penetrating porcine belly, respectively. The 
acetone dip for these devices made the material too fragile to penetrate the tissue models 
effectively. The narrowed device design for these prototypes proved to be effective in 
naturally allowing the device arms to flex through the trocar without acetone treatment. 
  
Figure 85: No Acetone Treatment Devices Plot of Insertion Force and Delivery Force. 
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Figure 86: Acetone Devices Plot of Insertion Force and Delivery Force. 
 
Figure 87: Broken Acetone treated device during delivery into dragon skin silicone. 
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Figure 88: Successful delivery of non-acetone treated device into porcine belly. 
4.3 Cadaver Studies Results 
4.3.1 Cadaver 1 Study 
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All Hares devices broke during delivery
Cadaver 1 Results
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The devices labeled “Hares” in this study corresponded to the device that were 
made with the most updated device design described in the methods of this study. The 
devices labeled “Previous” correspond to the devices that were made by the previous 
student. The “Hares” devices broke upon delivery into the cadaver tissue at an average 
tensile force of 13.16lbs. The “Previous” devices had stress notches when passing 
through the trocar and required an average of 7.34lbs. The “Previous” devices delivered 
into the cadaver tissue required an average of 18.29lbs force to penetrate the tissue. The 
insertion force for the “Hares” devices was an average of 5.31lbs lower to pass through 
the trocar. The insertion force of the “Full devices was described as an acceptable amount 
of force to apply when pushing a device into the trocar, per the surgeon. The surgeon also 
mentioned that having a delivery force of 18.29lbs was too great for surgeons to perform 
in live laparoscopic procedures. Figure 90 and Figure 91 show the delivery and insertion 
of the “Previous” devices in the abdominal cavity. 
 








Figure 91: Delivery of the "Previous" device into cadaver tissue to plug trocar site. 
After the “Hares” devices showed a consistent pattern of failure a new method 
was attempted in delivering the TSCC device. Instead of pulling the device from the 
proximal stem, a TSCC device was broken at the stem and a laparoscopic tool was used 
to grip the device from the distal end as shown in Figure 92. The prototype device was 
successful upon delivery into the cadaver tissue (Figure 93). 
 
 
Figure 92: Hares devices (without stem) in cadaver abdominal cavity before delivery. 
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Figure 93: Successful plug of trocar site with "Hares" devices without device stem. 
  
4.3.2 Cadaver 2 Study 
Ten devices were inserted into the abdominal cavity of a cadaver through a 12mm 
car and delivered into the peritoneum and fascia. The trocar wound was successfully 
plugged and sealed for potential hernia prevention (Figure 95 and Figure 96). Five of 
each group were measured for insertion force and delivery force, and two from each 
group were measured for retention force in the cadaver tissue. The average values 
measured were 2.57lbs, 11.78lbs, 6.98 lbs, respectively (Figure 94). These devices 
differed in their barb design. The one barb devices were more effective in delivering into 
tissue because of the less resistance occurring on one barb device when compared to two 
barb devices. The second barb on the two barb devices proved to be too much resistance 
in some cases and led to device failure for 3/5 devices inserted. The bar chart shows the 
tensile break point in this case. The great variability found in the measurement of the 
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retention force is likely due to the difficulty in measuring retention force in live tissue. 
Pushing the devices out was hard to capture when the devices needed to be pushed into 
the intestines of the animal.   
  
Figure 94: Bar Plot of Insertion, Delivery, and Retention Force in Cadaver Lab. 
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Figure 95: Successful Device Delivery into Cadaver Tissue. 
  
Figure 96: Delivery of TSCC into Cadaver Tissue. 
4.4 Short Chronic Animal Study Results 
4.4.1 Animal Study Results 
Three animal chronic animal studies were conducted at the RRC. Each of the 
three pigs were kept alive for seven days before being euthanized. From the three 
animals, Figure 97 shows the histogram of the surgery outcomes. In the first pig from the 
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study, two surgeons took turns using the device. For consistency, for the second two pigs, 
only one surgeon from the first study delivered the TSCC. 
 
Figure 97: Pie Chart of Surgery Outcomes in Chronic Animal Study. 
Three devices resulted in good successful plugs. Four devices had only one arm 
pierce the tissue. Eight devices resulted in a procedural error when inserting/delivering 
the device into the tissue. These procedural errors were classified as instances that the 
device slipped during delivery into the tissue, the surgeon mentioned that “he/she didn’t 
think they had applied enough force to deliver the device, or the device was jammed in 
the device applicator after delivery and the surgeon had to break the device to free the 















Pie Chart of Surgery Outcomes
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Figure 98: Pie Chart of Necropsy Outcomes in Chronic Animal Study. 
Three devices had successful retention in the tissue after seven days, four of them 
resulted in just one arm stem remaining in tissue after seven days, ten trocar wounds were 
open and did not have a device penetrating, and one trocar wound herniated displaying 
the bulging of tissue through the open trocar wound. There weren’t hand-held force 
gauge measurements during the animal trials. Therefore, it was difficult to determine the 
force at which the devices failed to penetrate the pig tissue and the peak force that the 
surgeon felt like he wasn’t pulling hard enough. This information would have been 














Pie Chart of Necropsy Outcomes
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during surgery. Figure 99 through Figure 103 show examples of the categories the 
necropsy results were grouped in.  
 
Figure 99: Example of Open Trocar Wound (was not properly plugged) Found in Necropsy. 
 
Figure 100: Example of Herniated Trocar Wound Found in Necropsy. 
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Figure 101: Example of Successful TSCC Found in Necropsy. 
 
Figure 102: Example of TSCC That Only Had One Arm Penetrate Tissue Found in Necropsy. 
 
Figure 103: Example of TSCC that had been encompassed by peritoneal tissue (Open Wound). 
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4.4.2 Histological Findings 
In the study, the harvested specimens from the animal study were shipped for 
histology. The goal of histology was to qualify/compare the presence of new collagen 
fibers near the incision site, the implanted device, healing around the wound, and get an 
overall assessment of the biocompatibility of PLA devices in live tissue. Devices found in 
the three pigs that displayed a good seal, hernia, one side penetration of the device, 
biodegradation were sent in for histology along with one specimen from each animal that 
recovered by normal healing and no tissue penetration (as a control). Figure 103 shows a 
diagram from the list of instructions that were sent to histology for the preparation of 
slides. 
 
Figure 104: Diagram from Histology Instructions. 
  A total of 13 of the 18 collected specimens were sent for slide preparation with 
trichrome blue staining. Five slides were prepared for each specimen at varying levels of 
depth in the tissue. From the prepared slides a pathologist, analyzed the slides and 
annotated the healing progression and the cellular findings. The pathologist was given 
samples that did not have a trocar closure clip as controls (Figure 98) to compare the 
histological findings. 
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The samples submitted can be categorized to samples that had one arm of a device 
penetrate and hold in the porcine tissue (Figure 102), had resulted in a herniation of 
omental tissue (Figure 101), had been encompassed by the peritoneum (Figure 103), and 
had a device that successfully plugged the trocar wound site (Figure 101). From the 
samples that resulted in successful trocar wound closure, the pathologist wrote: “The 
implant site demonstrates layers of muscle tissue and connective tissue with a core region 
of collagen proliferation interspersed with neutrophils, macrophages and scattered 
multinucleated giant cells. Deep in the tissue is a dense aggregation of collagen 
interspersed with foreign material associated with multinucleated giant cells and 
macrophages. The material in the multinucleated giant cells and macrophages is 
interpreted as implant material that is undergoing phagocytosis. There are several foci 
where the multinucleated cells with foreign material are outside the collagen 
aggregation.” Later in his reports, the pathologist commented on that “there is no 
suggestion of toxicity or infection in these sites” of all the sites altogether. 
Figure 105 shows the slide of sample in which a device successfully plugged the 
trocar closure site. From the slide, the pathologist notes that the “Granulation tissue and 
fibrosis are stained blue with Masson's. The dark blue is likely existing connective tissue 
stroma. The light blue is developing granulation tissue or fibrosis---this occurs during 




Figure 105: Picture of Slide from Pathologist. 
 









V. DISSCUSSION & CONCLUSION
The primary objective of this MEng thesis was to fabricate and validate a device 
that proves the concept of using a biocompatible PLA clip to plug and seal a trocar 
wound site preventing an opportunity for postoperative herniation. 
The devices developed and tested in this study prove the concept that a PLA clip 
can be used to plug and seal a 12mm trocar wound site preventing an opportunity for 
postoperative herniation. 
A testing of PLA devices in cadaver tissue show that the TSCC clips are flexible 
enough to travel through a 12mm trocar without plastic deformation, can penetrate 
cadaver tissue and plug a trocar wound, and are rigid enough to be retained in the tissue. 
From chronic animal studies it is shown that the PLA device used in testing is 
non-toxic and exhibits appropriate biocompatibility for the scope of this device. There are 
factors that could have limited the results of this thesis. After the second design update of 
the TSCC with a manual taper on the device arms, the repeatability and consistency of 
the devices decreased. Without having a mold or machinery to shape the tapered design 
of the TSCC, the results of the studies included an increased variability. Also, not having 
a specifically designed applicator tool for the devices and having to manually stamp the 
devices after re-heating the devices created an offset of the arms. The magnitude of this 
offset could not be predicted and therefore, each TSCC had a vulnerable failure point on 
one side of the device. While re-heating the stem of the device for stamping, the heat was 
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not always concentrated onto the stem of the device, therefore, the device arms in some 
cases were affected. 
Due to the weight of the hand-held gauge along with the length and awkwardness 
of the entire set-up, the measurements during cadaver lab sessions could have been 
affected. In addition, the hand-held force gauge was creating an unorthodox way to 
deliver the device into the abdominal wall. Due to the structured way devices were 
benchtop tested with a load frame, the position in benchtop testing didn’t always correlate 
to the position the device was delivered in the cadaver lab or pig. With the load frame the 
device was always vertical and, in the cadaver/animal an organic torque was introduced 
because of the natural curve of the abdominal cavity. This was unmeasurable during the 
study. 
 
Figure 107: Depiction of the torque generated by a non-perpendicular abdominal cavity. 
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Lastly, the applicator was a limitation in this study. The applicators used in the 
latter half of this study were existing laparoscopic tools. The TSCC devices had to be 
deformed and manipulated to conform to the distal design and the grip of the lap tool 
applicators compromising the integrity of the PLA. Also, the length of the applicators 
was too long and awkward during device delivery creating torque on the device arms. If 
the applicator was custom designed, these limitations created could have been mitigated. 
In summary, a PLA trocar closure clip was used to plug and seal a 12mm trocar 
wound preventing postoperative herniation. However, the design and manufacturing of 
the device is critical along with the applicator used to deliver the device. From the results 
obtained in the chronic animal trials, the theory of this proposal was validated. Although, 
the results were not consistent, the concept of using plugging a trocar wound site closed 
with a PLA clip was shown to be effective. Of the 11 open wounds from the chronic 
animal trial, one open wound resulted in herniation of tissue. Post-operative herniation is 
a legitimate risk that can be mitigated with proper blocking of the trocar site. 
For the future of the work performed in this thesis, a couple recommendations can 
be made. There is a need to design an injection mold for the updated designed TSCC 
instead of using 3D printing. This method will decrease the amount of waste in the 
manufacturing of the devices and will allow the PLA to be formed and then cooled into 
the exact shape with the taper intended along with the proximal pattern so that the device 
is compatible with the applicator. After the manufacturing steps for the TSCC are 
completely mechanized, follow-up animal labs should be conducted to show efficacy of 
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the manufacturing process and the TSCC. In addition, a custom applicator device should 
be designed for the TSCC. This will deter users of the device from using their own 
applicator with the TSCC which would minimize user errors. If the applicator is designed 
specifically for the TSCC both can be testing in conjunction for efficacy. The critical 
design components of the TSCC are the length of the shaft, distal grip design, and the 
releasing mechanism of the applicator.  
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6.5 IACUC Chronic Animal Study Application 
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